Systematic review on the management of chronic constipation in North America

American Journal of Gastroenterology

Volumn 100, Issue SUPPL.1, 2005, Pages s5-s21

  Brandt, Lawrence J ^a   Prather, Charlene M ^b   Quigley, Eamonn M M ^c   Schiller, Lawrence R ^d   Schoenfeld, Philip ^e   Talley, Nicholas J ^f  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY COLLEGE CORK   (Ireland)

^d BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^f MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISACODYL; BULKING AGENT; CARTERS PILL; CORRECTOL; DOCUSATE CALCIUM; DOCUSATE SODIUM; HERBACEOUS AGENT; ISPAGULA; KRISTALOSE; LACTULOSE; LAXATIVE; MACROGOL; MACROGOL 3350; MAGNESIUM HYDROXIDE; METHYLCELLULOSE; MINERAL OIL; OSMOTIC AGENT; PERDIEM FIBER THERAPY; PHENOLPHTHALEIN; PLACEBO; POLYCARBOPHIL CALCIUM; SENNA EXTRACT; SENOKOT; TEGASEROD; UNCLASSIFIED DRUG;

ABDOMINAL CRAMP; ABDOMINAL PAIN; ANAPHYLAXIS; ANORECTAL PRESSURE; BIOFEEDBACK THERAPY; BLOATING; BRAN; CHRONIC CONSTIPATION; CLINICAL TRIAL; COLON OBSTRUCTION; CONSTIPATION; CONTROLLED CLINICAL TRIAL; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INDICATION; DRUG MECHANISM; EPIDEMIOLOGICAL DATA; ESOPHAGUS OBSTRUCTION; EVIDENCE BASED MEDICINE; FEEDBACK SYSTEM; FLATULENCE; HUMAN; HYPERCALCEMIA; HYPERMAGNESEMIA; HYPERPHOSPHATEMIA; HYPOKALEMIA; HYPONATREMIA; HYPOVOLEMIA; INTESTINE MOTILITY; ISCHEMIC COLITIS; LIVER TOXICITY; METHODOLOGY; NAUSEA; PATIENT EDUCATION; POSTMARKETING SURVEILLANCE; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SELF REPORT; SEX RATIO; SIDE EFFECT; SYMPTOM; SYSTEMATIC REVIEW; TRAINING; TREATMENT INDICATION; WEIGHT REDUCTION;

EID: 22844441856     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2005.50613_2.x     Document Type: Review

References (86)

1. Hayward R, Wilson M, Tunis S, et al. User's guides to the medical literature: VIII. How to use clinical practice guideline recommendations. A. Are the recommendations valid? JAMA 1995;274:570-74.
2. Wilson M, Hayward R, Tunis S, et al. User's Guide to the medical literature: VIII. How to use clinical practice guidelines. B. What are the Recommendations and will they help you in caring for your patients. JAMA 1995;274:1630-32.
3. Guyatt G, Sackett D, Sinclair J, et al. User's guide to the medical literature. IX. A method for grading health care recommendations. JAMA 1995;274:1800-4.
4. Brandt L, Bjorkman D, Fennerty MB, et al. Systematic review on the management of irritable bowel syndrome in North America. Am J Gastroenterol 2002;97:S7-S27.
5. Egger M, Smith GD. Principles of and procedures for systematic reviews. In: Egger M, Smith GD, Attman DG, eds. Systematic reviews in health care, 2nd Ed. London: BMJ Publishing Group, 2001:23-43.
6. Oxman A, Guyatt G, Cook D, et al. Summarizing the Evidence. In: Guyatt G, Rennie D, eds. User's guide to the medical literature: A manual for evidence-based clinical practice, 1st ed. Chicago: AMA Press, 2001:155-75.
7. Cook D, Guyatt G, Laupacis A, et al. Rules of evidence and clinical recommendations on the use of anti-thrombotic agents. Chest 1992;102(Suppl 4):3055-115.
8. Van Zanten SJO, Talley NJ, Bytzer P, et al. Design of treatment trials for functional gastrointestinal disorders. Gut 1999;45(Suppl II):II69-II77.
9. Jadad A, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized controlled trials: Is blinding necessary? Controlled Clin Trials 1996;17:1-12.
10. Schoenfeld P, Cook D, Hamilton F, et al. An evidence based approach to gastroenterology therapy. Gastroenterology 1998;114:1318-25.
11. Schulz KF, Chalmers I, Hayes RJ, et al. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273:408-12.
12. Chalmers TC, Celano P, Sacks HS, et al. Bias in treatment assignment in controlled clinical trials. N Engl J Med 1983;309:1358-61.
13. Drossman DA, Punch-Jensen P, Janssens J et al. Identification of subgroups of functional bowel disorders. Gastroenterol Int 1990;3:159-72.
14. Thompson WG, Longstreth GF, Drossman DA, et al. Functional bowel disorders and functional abdominal pain. Gut 1999;45(suppl 2):II43-47.
15. Thompson WG, Heutan KW, Smyth GT, et al. Irritable bowel syndrome: The view from general practice. Eur J Gastroenterol Hepatol 1997;9:689-92.
16. Ashraf W, Park F, Lof J, et al. An examination of the reliability of reported stool frequency in the diagnosis of idiopathic constipation. Am J Gastroenterol 1996;91:26-32.
17. Dorland's Pocket Medical Dictionary. Friel JP, ed. 22nd ed. Philadelphia: WB. Saunders, 1997.
18. Irvine EJ, Ferrazzi S, Pare P, et al. Health-related quality of life in functional GI disorders: Focus on constipation and resource utilization. Am J Gastroenterol 2002;97:1986-93.
19. Higgins PDR, Johnson JF. Epidemiology of chronic constipation in North America: A systemic review. Am J Gastroenterol 2004;99:750-9.
20. Pare P, Ferrazi S, Thompson WG, et al. An epidemiological survey of constipation in Canada: Definitions, rates, demographics, and predictors of health care seeking. Am J Gastroenterol 2001;96:3130-7.
21. Hammond E. Some preliminary findings on physical complaints from a prospective study of 1,064,004 men and women. Am J Pub Health Nations Health 1964;54:11-23.
22. Sandier RS, Jordan MC, Shelton BJ. Demographic and dietary determinants of constipation in the US population. Am J Pub Health 1990;80:185-9.
23. Everhart JE, Go VL, Johannes RS, et al. A longitudinal survey of self-reported bowel habits in the United States. Dig Dis Sci 1989;34:1153-62.
24. Johanson JF. Constipation. In: Everhart JE, ed. Digestive diseases in the United States: Epidemiology and impact. Vol. 94-1447. Washington, DC: U.S. Department of Health and Human Resources, Public Health Service, National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Disease, 1994:5667-94.
25. Harari D, Gurwitz JH, Avorn J, et al. Bowel habit in relation to age and gender. Findings from the National Health Interview Survey and clinical implications. Arch Intern Med 1996;156:315-20.
26. Talley NJ, Zinsmeister AR, Van Dyke C, et al. Epidemiology of colonie symptoms and the irritable syndrome. Gastroenterol 1991;101:927-34.
27. Talley NJ, Weaver AL, Zinsmeister AR, et al. Functional constipation and outlet delay: A population-based study. Gastroenterol 1993;105:781-90.
28. Drossman DA, Li Z, Andruzzi E, et al. U.S. house-holder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993;38:1569-80.
29. Stewart WF, Liberman JN, Sandler RS, et al. Epidemiology of constipation (EPOC) study in the United States: Relation of clinical subtypes to sociodemographic features. Am J Gastroenterol 1999;94:3530-40.
30. Saito Y, Schoenfeld P, Locke GR. Epidemiology of irritable bowel syndrome in North America-A systematic review. Am J Gastroenterol 2002;97:1910-5.
31. Talley NJ, Dennis EH, Schettler-Duncan VA, et al. Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea. Am J Gastroenterol 2003;98:2454-9.
32. Locke GR, III, Zinsmeister AR, Fett SL, et al. Overlap of gastrointestinal symptom complexes in a USA community. Neurogastroenterol Motil 2004;16:1-6.
33. Talley NJ, Weaver AL, Zinsmeister AR, et al. Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol 1992;136:165-77.
34. Locke GR, III, Pemberton JH, Phillips SF. AGA technical review on constipation. Gastroenterol 2000;119:1161-78.
35. Cash BD, Schoenfeld P, Chey WD. The utility of diagnostic tests in irritable bowel syndrome patients: A systematic review. Am J Gastroenterol 2002;97:2812-9.
36. Lijmer JG, Mol BW, Heisterkamp S, et al. Empirical evidence of design-related bias in studies of diagnostic tests. JAMA 1999;282:1061-6.
37. Pepin C, Ladabaum U. The yield of lower endoscopy in patients with constipation: Survey of a university hospital, a public county hospital, and a Veterans Administration medical center. Gastrointest Endosc 2002;56:325-32.
38. American Society for Gastrointestinal Endoscopy Practice Parameters Committee. Guideline on the Use of Endoscopy in the Management of Constipation. ASGE Press, 2005. in press.
39. Patriquin H, Martelli H, Devroede G. Barium enema in chronic constipation: Is it meaningful? Gastroenterol 1978;75:619-22.
40. Gerson DE, Lewicki AM, McNeil BJ, et al. The barium enema; evidence for proper utilization. Radiology 1979;130:297-301.
41. Wald A. Diagnosis of constipation in primary and secondary care. Rev Gastroenterol Disord 2004;4(suppl. 2):S28-33.
42. Lembo A, Camilleri M. Chronic Constipation. N Engl J Med 2003;349:1360-8.
43. Xing JH, Soffer E. Adverse effects of laxatives. Dis Colon Rectum 2001;44:1201-9.
44. Cheskin LJ, Kamal N, Crowell MD, et al. Mechanisms of constipation in older persons and effects of fiber compared with placebo. J Am Geriatr Soc 1995;43:666-9.
45. Fenn GC, Wilkinson PD, Lee CE, et al. A general practice study of the efficacy of Regulan in functional constipation. Br J Clin Pract 1986;40:192-7.
46. Ashraf W, Park F, Lof J, et al. Effects of psyllium therapy on stool characteristics, colon transit and anorectal function in chronic idiopathic constipation. Aliment Pharmacol Ther 1995;9:639-47.
47. Dettmar PW, Sykes J. A multi-centre, general practice comparison of ispaghula husk with lactulose and other laxatives in the treatment of simple constipation. Curr Med Res Opin 1998;14:227-33.
48. Rouse M, Chapman N, Mahapatra M, et al. An open, randomised, parallel group study of lactulose versus ispaghula in the treatment of chronic constipation in adults. Br J Clin Pract 1991;45:28-30.
49. Mamtani R, Cimino JA, Kugel R, et al. A calcium salt of an insoluble synthetic bulking laxative in elderly bedridden nursing home residents. J Am Coll Nutr 1989;8:554-6.
50. Hamilton JW, Wagner J, Burdick BB, et al. Clinical evaluation of methylcellulose as a bulk laxative. Dig Dis Sci 1988;33:993-8.
51. Badiali D, Corazziari E, Habib FI, et al. Effect of wheat bran in treatment of chronic nonorganic constipation. A double-blind controlled trial. Dig Dis Sci 1995;40:349-56.
52. Anderson AS, Whichelow MJ. Constipation during pregnancy: Dietary fibre intake and the effect of fibre supplementation. Hum Nutr Appl Nutr 1985;39:202-7.
53. Graham DY, Moser SE, Estes MK. The effect of bran on bowel function in constipation. Am J Gastroenterol 1982;77:599-603.
54. Tramonte SM, Brand MB, Mulrow CD, et al. The treatment of chronic constipation in adults: A systematic review. J Gen Intern Med 1997;12:15-24.
55. Jones MP, Talley NJ, Nuyts G, et al. Lack of objective efficacy of laxatives in chronic constipation. Dig Dis Sci 2002;47:2222-30.
56. Castle SC, Cantrell M, Israel DS, et al. Constipation prevention: Empiric use of stool softeners questioned. Geriatrics 1991;46:84-6.
57. Hyland CM, Foran JD. Dioctyl sodium sulphosuccinate as a laxative in the elderly. Practitioner 1968;200:698-9.
58. Fain AM, Susat R, Herring M, et al. Treatment of constipation in geriatric and chronically ill patients: A comparison. S Med Assoc J 1978;71:677-80.
59. McRorie JW, Daggy BP, Morel JG, et al. Psyllium is superior to docusate sodium for treatment of chronic constipation. Aliment Pharmacol Ther 1998;12:491-7.
60. Xing JH, Soffer E. Adverse effects of laxatives. Dis Colon Rectum 2001;44:1201-9.
61. Bass P, Dennis S. The laxative effects of lactulose in normal and constipated subjects. J Clin Gastroenterol 1981;3:23-8.
62. Sanders JF. Lactulose syrup assessed in a double-blind study of elderly constipated patients. J Am Geriatr Soc 1978;26:236-9.
63. Wesselius-De Casparis A, Braadbaart S, Bergh-Bohlken GE, et al. Treatment of chronic constipation with lactulose syrup: Results of a double-blind study. Gut 1968;9:84-6.
64. Andorsky RI, Goldner F. Colonic lavage solution (polyethylene glycol electrolyte lavage solution) as a treatment for chronic constipation: a double-blind, placebo-controlled study. Am J Gastroenterol 1990;85:261-5.
65. Cleveland MV, Flavin DP, Ruben RA, et al. New polyethylene glycol laxative for treatment of constipation in adults: A randomized, double-blind, placebo-controlled study. S Med Assoc J 2001;94:478-81.
66. Corazziari E, Badiali D, Habib FI, et al. Small volume isosmotic polyethylene glycol electrolyte balanced solution (PMF-100) in treatment of chronic nonorganic constipation. Dig Dis Sci 1996;41:1636-42.
67. Corazziari E, Badiali D, Bazzocchi G, et al. Long term efficacy, safety, and tolerability of low daily doses of isosmotic polyethylene glycol electrolyte balanced solution (PMF-100) in the treatment of functional chronic constipation. Gut 2000;46:522-6.
68. DiPalma JA, DeRidder PH, Orlando RC, et al. A randomized, placebo-controlled, multicenter study of the safety and efficacy of a new polyethylene glycol laxative. [comment]. Am J Gastroenterol 2000;95:446-50.
69. Freedman MD, Schwartz HJ, Roby R, et al. Tolerance and efficacy of polyethylene glycol 3350/electrolyte solution versus lactulose in relieving opiate induced constipation: A double-blinded placebo-controlled trial. J Clin Pharmacol 1997;37:904-7.
70. Attar A, Lemann M, Ferguson A, et al. Comparison of a low dose polyethylene glycol electrolyte solution with lactulose for treatment of chronic constipation. Gut 1999;44:226-30.
71. Kinnunen O, Salokannel J. Constipation in elderly long-stay patients: Its treatment by magnesium hydroxide and bulk-laxative. Ann Clin Res 1987;19:321-3.
72. Xing JH, Soffer E. Adverse Effects of Laxatives. Dis Colon Rectum 2001;44:1201-9.
73. MacLennan WJ, Pooler A. A comparison of sodium picosulphate ("Laxoberal") with standardised senna ("Senokot") in geriatric patients. Curr Med Res Opin 1974;2:641-7.
74. McCallum G, Ballinger BR, Presly AS. A trial of bran and bran biscuits for constipation in mentally handicapped and psychogeriatric patients. J Hum Nutr 1978;32:369-72.
75. Rider JA. Treatment of acute and chronic constipation with bisoxatin acetate and bisacodyl. Double-blind crossover study. Curr Ther Res Clin Exp 1971;13:386-92.
76. Connolly P, Hughes IW, Ryan G. Comparison of "Duphalac" and "irritant" laxatives during and after treatment of chronic constipation: A preliminary study. Curr Med Res Opin 1974;2:620-5.
77. Camilleri M. Review article: Tegaserod. Aliment Pharmacol Ther 2001;15:777-89.
78. Prather CM, Camilleri M, Zinsmeister AR, et al. Tegaserod accelerates oro-cecal transit in patients with constipation-predominant irritable bowel syndrome. Gastroenterol 2000;118:463-8.
79. 4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects. Aliment Pharmacol Ther 2001;15:1745-51.
80. Johanson J, Wald A, Tougas G, et al. Effect of tegaserod in chronic constipation: A randomized, double-blind, controlled trial. Clin Gastroenterol Hepatol 2004;2:796-805.
81. Kamm M, Muller-Lissner S, Talley NJ, et al. Tegaserod for the treatment of chronic constipation: A randomized, double blind, placebo-controlled multinational study. Am J Gastroenterol 2005;100:372-82.
82. Briefing document on Zelnorm (Tegaserod) for the FDA Joint GI Drugs Advisory Committee and Drug Safety and Risk Management Sub-Committee. July 14, 2004
83. Odes HS, Madar Z. A double-blind trial of a celandin, aloe vera, and psyllium laxative preparation in adult patients with constipation. Digestion 1991;49:65-71.
84. Tolia V, Lin CH, Elitsur Y. A prospective randomized study with mineral oil and oral lavage solution for treatment of faecal impaction in children. Aliment Pharmacol Ther 1993;5:523-29.
85. Sondheimer JM, Gervaise EP. Lubricant versus laxative in the treatment of chronic functional constipation of children: A comparative study. J Pediatr Gastroenterol Nurs 1982;1:223-6.
86. Heyman S, Jones R, Scarlett Y, et al. Biofeedback treatment of constipation: A critical review. Dis Colon Rectum 2003;46:1208-17.